In decision T 438/19 Technical Board of Appeal 3.3.03 has ex officio (!) referred three questions of law to the Enlarged Board of Appeal (now handled as G 1/23) in order to resolve a perceived divergence in the case law. These questions concern the question whether and in how far a (commercial) product and technical…
With less than 2 weeks to go before 1 June 2023, it was about time for the UPC to tie several loose ends and to clarify various questions before becoming (more or less) fully operative. Here is an overview of what I found to be the most interesting news. 1.) Seat of the 3rd Subdivision…
The concept of plausibility has caused great controversy in European patent law in recent years. It was hoped that the decision of the Enlarged Board of Appeal (EBA) of the EPO in G 2/21 would bring clarity. Since the referral questions by Board 3.3.02 were very clear and seemed to present reasonable alternatives from which…
In June 2022 the EPO announced the project “Bringing Teams Together”, introducing a new management of office space with the aim “to ensure that teams cluster in our buildings when working on site”. The project proved to be a bit challenging since the EPO management simultaneously intended to empty the Pschorrhöfe 1-4 buildings that had…
In the spirit of Jonathan Swift’s unforgettable Modest Proposal for preventing the Children of Poor People from being a Burthen to Their Parents or Country and for making them beneficial to the Publick, Let us first consider a Modest Proposal of how the European Patent Office could be restructured to achieve • 100% EPO Quality…
Cornelia Rudloff-Schäffer is about to leave the German Patent and Trademark Office whose President she has been for 14 years. On 31 January 2023 she will enter into her well-deserved retirement. This should not remain unnoticed on this blog, even though others are more qualified to praise her merits and appraise the GPTO’s achievements during…
The new and noteworthy decision T 670/20 by Technical Board of Appeal 3.3.07 provides more legal certainty for patentees of formulation patents. The proprietors of pharmaceutical formulation and pharmaceutical use patents do often not have it easy, if and when – as is often the case – they have conducted clinical trials before the priority…
Damocles, so tells us an ancient legend (reported here) was a favorite of President Dionysios II. of Syrakus in Sicily, who lived during the first half of the 4th century BC. His story was succinctly told by none other than Marcus Tullius Cicero in his tusculanae disputationes 5, 61–62. Hoping that Cicero will forgive me,…
The UPC website has the breaking news of the day: The start of the UPC Sunrise Period is postponed for two months until March 1, 2023. This is time for relief and gratitude. And while today is Mozart’s day of death, I would like to express it in Bach / Picander’s words from the Christmas…
Concerto Italiano – Preludio Johannes Karcher, acting chairman of the UPC’s Administrative Committee, is to be applauded for the interview he gave to the Kluwer Patent blogger recently, which sheds at least a little more light on the issues still to be addressed before the Unified Patent Court can go “live”. There are quite a…
